Ning Liao

Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status

Guochun Zhang, Chongyang Ren, Cheukfai Li et al. · BMC Medicine · 2022 · 132 citations · Full text

Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial

Zefei Jiang, Massimo Cristofanilli, Zhi‐Ming Shao et al. · Annals of Oncology · 2013 · 61 citations

Prognostic Biomarkers, Metastatic Breast Cancer, Breast Oncology +10

An in-situ peptide-antibody self-assembly to block CD47 and CD24 signaling enhances macrophage-mediated phagocytosis and anti-tumor immune responses

Weiqi Zhang, Yinghua Zeng, Qiuqun Xiao et al. · Nature Communications · 2024 · 42 citations · Full text

Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy

Kun Wang, Quantong Deng, Ning Liao et al. · Tumor Biology · 2012 · 36 citations

A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer

Teng Zhu, C. L. Liu, Y. F. Zhang et al. · Breast Cancer Research and Treatment · 2016 · 30 citations

Surgical Oncology, Breast Oncology, Phase Ii Trial +8